临床药师参与1例社区获得性MRSA肺炎治疗的病例报告(3)
[4]Sakoulas G，Gold HS，Cohen RA，et al.Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia[J]. Journal of Antimicrobial Chemotherapy，2006，57(4)：699.
[5]Chuma M，Makishima M，Imai T，et al.Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients[J]. Ther Drug Monit，2018，40(1)：109-114.
[6]方潔，何乐，程齐俭.中国成人万古霉素给药剂量的商榷[J]. 中国感染与化疗杂志，2014(4)：291-294.
[7]Cao G，Liang X，Zhang J，et al.Vancomycin serum trough concentration vs. clinical outcome in patients with gram‐positive infection： a retrospective analysis[J].Journal of Clinical Pharmacy & Therapeutics，2015，40(6)：640-644.
[8]Ravina KPD，Susan LDPD，Thomas NTPD，et al.Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort[J].Pharmacotherapy，2012，32(3)：195-201.
[9]Park KH，Kim ES，Kim HS，et al.Comparison of the clinical features， bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus[J]. J Antimicrob Chemother，2012，67(8)：1843-1849.
[10]梁晓宇，吴菊芳，杨敏婕，等.万古霉素治疗药物浓度监测队列研究[J].中国感染与化疗杂志，2015(5)：472-478., 百拇医药(吴国才)
[5]Chuma M，Makishima M，Imai T，et al.Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients[J]. Ther Drug Monit，2018，40(1)：109-114.
[6]方潔，何乐，程齐俭.中国成人万古霉素给药剂量的商榷[J]. 中国感染与化疗杂志，2014(4)：291-294.
[7]Cao G，Liang X，Zhang J，et al.Vancomycin serum trough concentration vs. clinical outcome in patients with gram‐positive infection： a retrospective analysis[J].Journal of Clinical Pharmacy & Therapeutics，2015，40(6)：640-644.
[8]Ravina KPD，Susan LDPD，Thomas NTPD，et al.Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort[J].Pharmacotherapy，2012，32(3)：195-201.
[9]Park KH，Kim ES，Kim HS，et al.Comparison of the clinical features， bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus[J]. J Antimicrob Chemother，2012，67(8)：1843-1849.
[10]梁晓宇，吴菊芳，杨敏婕，等.万古霉素治疗药物浓度监测队列研究[J].中国感染与化疗杂志，2015(5)：472-478., 百拇医药(吴国才)